Table 2 Clinical and pathological characteristics of metachronous recurrent IPMNs

From: Metachronous intraductal papillary mucinous neoplasms disseminate via the pancreatic duct following resection

Patient

 

Primary IPMNs

Recurrent lesions

Age/Sex

Cyst size (mm)

MPD diameter (mm)

Operation

Histology

Depth of invasion (mm)

LVI

Resection margin

Histology

Time to second operation (years)

1

81/M

20

10

DP

HGD

0

Negative

INV

2.1

2

74/F

20

6

DP

INV

2

Negative

Negative

HGD

1.9

3

74/M

60

3

DP

HGD

0

LGD

HGD

2.5

4

73/M

30

8

Whipple

INV

1

Negative

Negative

INV

1.3

5

65/F

12

9

DP

LGD

0

LGD

INV

4.5

6

57/F

35

6

DP

HGD

0

Negative

INV

2.8

7

54/F

60

7

DP

HGD

0

Negative

INV

0.9

8

55/M

35

2

DP

INV

8

Negative

Negative

HGD

2

9

66/M

26

6

MP

HGD

0

Negative

Concomitant PDAa

4.4

  1. DP distal pancreatectomy, MP middle pancreatectomy, INV invasive carcinoma (IPMN-associated carcinoma), HGD high-grade dysplasia, LGD low-grade dysplasia, PDA pancreatic ductal adenocarcinoma, LVI lymphovascular invasion
  2. aPDA independently developed from the primary IPMN